208 related articles for article (PubMed ID: 35264673)
1. Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease.
Chung I; Park HA; Kang J; Kim H; Hah SM; Lee J; Kim HS; Choi WS; Chung JH; Shin MJ
Sci Rep; 2022 Mar; 12(1):3874. PubMed ID: 35264673
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of
Dilnashin H; Birla H; Keswani C; Singh SS; Zahra W; Rathore AS; Singh R; Keshri PK; Singh SP
ACS Chem Neurosci; 2023 Sep; 14(17):3077-3087. PubMed ID: 37579290
[TBL] [Abstract][Full Text] [Related]
3. α-Arbutin Protects Against Parkinson's Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo.
Ding Y; Kong D; Zhou T; Yang ND; Xin C; Xu J; Wang Q; Zhang H; Wu Q; Lu X; Lim K; Ma B; Zhang C; Li L; Huang W
Neuromolecular Med; 2020 Mar; 22(1):56-67. PubMed ID: 31401719
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of α-mangostin on mitochondrial dysfunction and α-synuclein aggregation in rotenone-induced model of Parkinson's disease in differentiated SH-SY5Y cells.
Hao XM; Li LD; Duan CL; Li YJ
J Asian Nat Prod Res; 2017 Aug; 19(8):833-845. PubMed ID: 28696167
[TBL] [Abstract][Full Text] [Related]
6. The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3.
Luo H; Peng C; Xu X; Peng Y; Shi F; Li Q; Dong J; Chen M
Mol Neurobiol; 2022 Apr; 59(4):2068-2084. PubMed ID: 35040040
[TBL] [Abstract][Full Text] [Related]
7. Glycitein exerts neuroprotective effects in Rotenone-triggered oxidative stress and apoptotic cell death in the cellular model of Parkinson's disease.
Dong N; Yang Z
Acta Biochim Pol; 2022 Jun; 69(2):447-452. PubMed ID: 35691030
[TBL] [Abstract][Full Text] [Related]
8. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
Rekha KR; Inmozhi Sivakamasundari R
Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
[TBL] [Abstract][Full Text] [Related]
9. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders?
Gore E; Duparc T; Genoux A; Perret B; Najib S; Martinez LO
Antioxid Redox Signal; 2022 Aug; 37(4-6):370-393. PubMed ID: 34605675
[No Abstract] [Full Text] [Related]
10. IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype.
Domínguez-Zorita S; Romero-Carramiñana I; Santacatterina F; Esparza-Moltó PB; Simó C; Del-Arco A; Núñez de Arenas C; Saiz J; Barbas C; Cuezva JM
Cell Death Dis; 2023 Jul; 14(7):413. PubMed ID: 37433784
[TBL] [Abstract][Full Text] [Related]
11. Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.
Jalewa J; Sharma MK; Hölscher C
J Neurochem; 2016 Oct; 139(1):55-67. PubMed ID: 27412483
[TBL] [Abstract][Full Text] [Related]
12. Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson's Disease Model by Alleviating Mitochondrial Dysfunction.
Aleksandrova Y; Chaprov K; Podturkina A; Ardashov O; Yandulova E; Volcho K; Salakhutdinov N; Neganova M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982914
[TBL] [Abstract][Full Text] [Related]
13. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells.
Nataraj J; Manivasagam T; Justin Thenmozhi A; Essa MM
Nutr Neurosci; 2017 Jul; 20(6):351-359. PubMed ID: 26856988
[TBL] [Abstract][Full Text] [Related]
15. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells.
Solaini G; Sgarbi G; Baracca A
Biochem Soc Trans; 2021 Apr; 49(2):815-827. PubMed ID: 33929490
[TBL] [Abstract][Full Text] [Related]
16. Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone.
Van Laar VS; Berman SB; Hastings TG
Neurobiol Dis; 2016 Jul; 91():247-61. PubMed ID: 27001148
[TBL] [Abstract][Full Text] [Related]
17. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1.
Geng J; Liu W; Gao J; Jiang C; Fan T; Sun Y; Qin ZH; Xu Q; Guo W; Gao J
Br J Pharmacol; 2019 Dec; 176(23):4574-4591. PubMed ID: 31389613
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-apoptotic L-DOPA precursors SuperDopa and SuperDopamide as potential neuroprotective agents for halting/delaying progression of Parkinson's disease.
Wiesen T; Atlas D
Cell Death Dis; 2022 Mar; 13(3):227. PubMed ID: 35277478
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo.
Wang T; Li C; Han B; Wang Z; Meng X; Zhang L; He J; Fu F
BMC Complement Med Ther; 2020 Jan; 20(1):20. PubMed ID: 32020857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
